These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11576576)

  • 1. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
    Ong CY; Liao AW; Cacho AM; Spencer K; Nicolaides KH
    Obstet Gynecol; 2001 Oct; 98(4):608-11. PubMed ID: 11576576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma placenta growth factor levels in midtrimester pregnancies.
    Tjoa ML; van Vugt JM; Mulders MA; Schutgens RB; Oudejans CB; van Wijk IJ
    Obstet Gynecol; 2001 Oct; 98(4):600-7. PubMed ID: 11576575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
    Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
    Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia.
    Tidwell SC; Ho HN; Chiu WH; Torry RJ; Torry DS
    Am J Obstet Gynecol; 2001 May; 184(6):1267-72. PubMed ID: 11349200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia.
    Su YN; Lee CN; Cheng WF; Shau WY; Chow SN; Hsieh FJ
    Obstet Gynecol; 2001 Jun; 97(6):898-904. PubMed ID: 11384693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
    Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
    Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Predictive Model at 11
    Chang Y; Chen X; Cui HY; Li X; Xu YL
    Reprod Sci; 2017 May; 24(5):783-789. PubMed ID: 27678097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies.
    Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(2):106-16. PubMed ID: 24457972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
    Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
    Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.